摘要
前列腺癌显着影响高度发达国家恶性肿瘤的总体发病率和死亡率。重要的风险因素包括家庭倾向和地区,种族和饮食因素。科学文献包含大量关于钙和乳制品在前列腺肿瘤转化过程中的作用的数据。这最有可能与钙离子浓度的变化控制如激素和神经递质分泌,环核苷酸水平,以及细胞生长,分裂和分化等多种生命过程有关。进行研究以证明由于钙离子浓度的差异引起的细胞周期控制紊乱可能对癌症的发展和预防至关重要。 体内钙稳态的紊乱可能由各种机制引起,如饮食中钙摄入过多,维生素D缺乏,维生素D受体(VDR),钙敏感受体(CaSR)和甲状旁腺激素的结构和功能改变受体(PTH-1-R),钙离子通道的变化,磷酸盐代谢紊乱(磷脂酶和Klotho蛋白),甲状旁腺激素相关蛋白(PTHrP)水平的变化等。 文章介绍了在分子水平上维持钙稳态的机制和遗传方面在前列腺癌的发病机制中起作用的数据。 引用前列腺癌中钙代谢异常机制的资料提示,饮食中需要个体化摄取这种元素,特别是在有PCa家族史的患者中。
关键词: 前列腺癌,癌症,钙,维生素D,甲状旁腺激素,磷酸盐。
Current Medicinal Chemistry
Title:Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer
Volume: 24 Issue: 38
关键词: 前列腺癌,癌症,钙,维生素D,甲状旁腺激素,磷酸盐。
摘要: Prostate cancer significantly affects the overall morbidity and mortality of malignant tumours in highly developed countries. Important risk factors include family predisposition and regional, racial and dietary determinants. The scientific literature contains a great deal of data on the role of calcium and dairy products in general in the process of neoplastic transformation of the prostate. This is most likely linked to the fact that changes in the concentration of calcium ions control such varied life processes as secretion of hormones and neurotransmitters, the level of cyclic nucleotides, and cell growth, division and differentiation. Research is conducted to demonstrate that disorders of cell cycle control due to differences in calcium ion concentrations may be crucial for the development and prevention of cancer.
Disturbances of calcium homeostasis in the body can be caused by various mechanisms, such as excessive calcium intake in the diet, vitamin D deficiency, structural and functional changes in vitamin D receptor (VDR), Calcium-Sensing Receptor (CaSR), and parathyroid hormone receptor (PTH-1-R), changes in calcium ion channels, phosphate metabolism disorders (phosphatonin and the Klotho protein), changes in the level of parathyroid hormone-related protein (PTHrP), and others.
The article presents data on the mechanisms maintaining calcium homeostasis at the molecular level and genetic aspects playing a role in the pathogenesis of prostate cancer.
The data cited on the occurrence of abnormal mechanisms of calcium metabolism in prostate cancer suggest the need for individualized intake of this element in the diet, especially in the case of patients with a family history of PCa.
Export Options
About this article
Cite this article as:
Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer, Current Medicinal Chemistry 2017; 24 (38) . https://dx.doi.org/10.2174/0929867324666170913102834
DOI https://dx.doi.org/10.2174/0929867324666170913102834 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug Repositioning Through Network Pharmacology
Current Topics in Medicinal Chemistry Lipid Nanoparticles for the Delivery of Biopharmaceuticals
Current Pharmaceutical Biotechnology The Functions of F-box Proteins in Regulating the Epithelial to Mesenchymal Transition
Current Pharmaceutical Design Novel Agents in Anticancer Drug Therapy I (Antiangiogenic Agents, Egfr Inhibitors)
Medicinal Chemistry Reviews - Online (Discontinued) Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy
Current Drug Targets Sirtuins: Novel Players in Male Reproductive Health
Current Medicinal Chemistry Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
Current Drug Targets Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Analytical and Pharmacological Aspects of Therapeutic Drug Monitoring of mTOR Inhibitors
Current Drug Metabolism From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Anti-Cancer Agents in Medicinal Chemistry From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Current Medicinal Chemistry Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Overview of Development and Formulation of <sup>177</sup>Lu-DOTA-TATE for PRRT
Current Radiopharmaceuticals Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets Editorial (Thematic Issue: New Advances of Drug Design in Cancer Disease Part II)
Current Bioactive Compounds Hypoxia and Fetal Heart Development
Current Molecular Medicine Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen
Current Radiopharmaceuticals Privileged 1,2,4-Oxadiazoles in Anticancer Drug Design: Novel 5- Aryloxymethyl-1,2,4-oxadiazole Leads for Prostate Cancer Therapy
Letters in Drug Design & Discovery